SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-033722
Filing Date
2015-02-04
Accepted
2015-02-04 16:25:05
Documents
8
Period of Report
2015-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d865242d8k.htm 8-K 17218
2 EX-1.1 d865242dex11.htm EX-1.1 193481
3 EX-5.1 d865242dex51.htm EX-5.1 13856
4 EX-99.1 d865242dex991.htm EX-99.1 10465
5 EX-99.2 d865242dex992.htm EX-99.2 10688
6 GRAPHIC g865242865242catlog.jpg GRAPHIC 6163
7 GRAPHIC g865242g67m16.jpg GRAPHIC 7822
8 GRAPHIC g865242g94z12.jpg GRAPHIC 4799
  Complete submission text file 0001193125-15-033722.txt   273322
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 15575805
SIC: 2834 Pharmaceutical Preparations